The presence of some fungal species in tumors predicts – and may even help drive – worse cancer outcomes, according to a study from Weill Cornell Medicine and Duke University researchers.
A new Cornell research project aims to gain a better understanding of how populations of microbes interact on surface environments, such as human skin, where their dynamics are not fully understood.
As doctoral students nearly 20 years ago, two Cornell researchers played an early role in the development of the work that was awarded the 2022 Nobel Prize in chemistry.
By analyzing key enzymes in a new way, an international team led by researchers at Weill Cornell Medicine has discovered how a well-known signaling molecule can either stimulate or suppress tumor growth depending on where it’s produced.
David Reetz, director of counseling and psychological services at the Rochester Institute of Technology, has been named Cornell’s new director of Counseling and Psychological Services; he will join Cornell in mid-December.
An advanced software tool for analyzing DNA sequences from tumor samples has uncovered likely new cancer-driving genes, in a study led by Weill Cornell Medicine researchers.
A cellular process known as autophagy that helps rid cells of debris may be impaired in pregnant women who go on to develop postpartum depression, according to new research from Weill Cornell Medicine.
